PMVP — PMV Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for PMV Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	101	361	297	241	203
Prepaid Expenses
Total Other Current Assets
Total Current Assets	102	365	301	247	207
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.739	0.569	13.2	20.5	19
Long Term Investments
Other Long Term Assets
Total Assets	103	366	332	270	252
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	4.52	6.41	12.2	10.8	14
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	4.57	6.41	23	24.3	26.5
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	98.5	359	309	246	226
Total Liabilities & Shareholders' Equity	103	366	332	270	252
Total Common Shares Outstanding